News and Comments

The Sky’s The Limit For Micromet’s BiTE Technology’s Capability

  Tuesday, July 19, 2011

Micromet (MITI) added another important collaborator, Amgen (AMGN), to a long list of large and small drug developing companies that are attracted to Micromet’s BiTE technology. Amgen/Micromet agreement looks fair for both. It fits Amgen’s strategy of focusing on adding next-generation products to its pipeline and helps Micromet’s financial requirements during the development of its promising proprietary cancer programs. Amgen wanted to select from among three BiTE-based drugs against three undisclosed solid tumor targets. The giant biotech will pay upfront, milestone, and other payments in a deal that could be worth over $900 million for the two selected drugs, or half of this amount if it selects only one drug, in addition to double-digit royalties in the event of approvals and sales. More...

Recent Postings



Adaptimmune (ADAP) CEMPRA (CEMP) Anacor (ANAC) Prolor Biotech (PBTH) Agenus (AGEN Idenix (IDIX) Rapamune ADVENTRIX (ANX) SERES THERAPEUTICS (MCRB) Amgen (AMGN) Intrexon (XON) C4 Therapeutics Global Cell Therapeutics (GBT) KERYX (KERX) Merck (MRK) Elan (ELN) Bellicum (BLCM) Prosensa (RNA) BIOMARIN (BMRN) NOVOCURE (NVCR) CRISPR Therapeutics (CRSP) INNOVIVA (INVA) Regeneron (REGN) Advaxis (ADXS) Theravance Bio Pharma (TBPH) Ariad (ARIA) Agenus (AGEN) Spike Therapeutics (ONCE) VANDA (VNDA) JOUNCE THERAPEUTICS (JNCE) RenenxBio (RGNX) Revlimid (lenolidamide) Array Pharmaceuticals (ARRY) IDERA (IDRA) ARGOS (ARGS) Mirati Therapeutics (MRTX) GlaxoSmithKline (GSK) PORTOLA (PTLA) Alnylam (ALNY) Dynavax (DVAX) Exelixis (EXEL) HALOZYME (HALO) ImmunoGen (IMGN) TOKAI (TKAOI) Ziofpharm (ZIOP) KITE (KITE) Incyte (INCY) Ridaforolimus Bristol-Myers Squibb (BMY) Zerenex Vertex (VRTX) Jazz Pharmaceuticals (JAZZ) Intermune (ITMN) Roche (ROCHE) Genentech MODERNA GUARDIAN HEALTH Inovio (INO) Auspex (ASPX) Sanofi (SNA) Pluristem (PSTI) NANTKWEST (NK) NEKTAR (NKTR)) OSI (OSIP) PTC Therapeutics (PTCT) Illumina (ILMN) SUNESIS PHARMACEUTICALS (SNSS) Sanofi (SNY) REGULUS (RGLS) Seattle Genetics (SGEN) Sequenom (SQNM) Xoma (XOMA) Onyx (ONXX) ABBVIE (ABBV) Galena (GALE) Sanofi-Aventis (SAN) Intercept (ICPT) CompuGen (CGEN) Vitae Pharmaceuticals (VTAE) AstraZeneca (AZN) SYNTA (SNTA) Telaprevir Ocular Therapeutix (OCUL) Abbott Laboratories (ABT) Aimmune Therapeutics (AIMT) Roche (RHHBY) ZALTRAP™ Biocryst (BCRX) Benlysta (belimumab) Human Genome Sciences (HGSI) Herceptin Alder Biopharmaceuticals (ALDR) Anadys (ANDS) Valeant Pharmaceuticals International (VRX) Cytokinetics (CYTK) ARCA (ABIO) Endometrial Cancer Biogen Idec (BIIB) Human Longevity (HLI) Dendreon (DNDN) ACADIA (ACAD) Multiple Myeloma Editas (EDIT) ISIS (ISIS) AERIE PHARMACEUTICALS Ionis (IONS) Gilead (GILD) galapagos (GLPG) Micromet (MITI) Sarepta (SRPT) Velcade (bortezomib) Trastuzumab-DM1 JUNO (JUNO) AGOS (ARGS) Theravance (THRX) Tysabri Sangamo (SGMO)